182 related articles for article (PubMed ID: 9663842)
1. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Hedenström H; Alm C; Kraft M; Grahnén A
Aliment Pharmacol Ther; 1997 Dec; 11(6):1137-41. PubMed ID: 9663842
[TBL] [Abstract][Full Text] [Related]
2. [The effect of ranitidine and famotidine on the intragastric pH profile of healthy subjects. Randomized cross-over trial with ranitidine effervescent tablets (300 mg) versus famotidine film tablets (40 mg) ].
Löser C; Burlage M; Fölsch UR
Arzneimittelforschung; 1994 May; 44(5):626-9. PubMed ID: 8024636
[TBL] [Abstract][Full Text] [Related]
3. In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
Arnestad JS; Kleveland PM; Waldum HL
Aliment Pharmacol Ther; 1997 Apr; 11(2):355-8. PubMed ID: 9146775
[TBL] [Abstract][Full Text] [Related]
4. Low-dose famotidine and effervescent cimetidine in healthy subjects: a placebo-controlled overnight pH study.
Reilly TG; Grimley CE; Usselmann B; Cottrell J; Mann SG; Raskin S; Nwokolo CU
Aliment Pharmacol Ther; 1998 May; 12(5):469-74. PubMed ID: 9663728
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
Lin CJ; Huang CL; Hsu HW; Chen TL
Acta Anaesthesiol Sin; 1996 Dec; 34(4):179-84. PubMed ID: 9084544
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
7. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
Hamilton MI; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
[TBL] [Abstract][Full Text] [Related]
8. Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.
Netzer P; Eschenmoser K; Halter F; Inauen W
Aliment Pharmacol Ther; 1999 Mar; 13(3):407-12. PubMed ID: 10102975
[TBL] [Abstract][Full Text] [Related]
9. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
Peghini PL; Katz PO; Castell DO
Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
[TBL] [Abstract][Full Text] [Related]
10. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
Pipkin GA; Mills JG
Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of ranitidine effervescent tablets and magnesium hydroxide-aluminium oxide on intragastric acidity. A single-centre, randomised, open cross-over study.
Propst A; Propst T; Judmaier G
Arzneimittelforschung; 1996 Jun; 46(6):621-4. PubMed ID: 8767354
[TBL] [Abstract][Full Text] [Related]
12. Effect of an evening dose of regular and effervescent formulations of ranitidine or cimetidine on intragastric pH in healthy volunteers.
Smout AJ; Jonkman JH; Peeters PA; De Bruin H
Aliment Pharmacol Ther; 1995 Feb; 9(1):51-6. PubMed ID: 7766744
[TBL] [Abstract][Full Text] [Related]
13. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
Tutuian R; Katz PO; Ahmed F; Korn S; Castell DO
Aliment Pharmacol Ther; 2002 Mar; 16(3):473-7. PubMed ID: 11876700
[TBL] [Abstract][Full Text] [Related]
14. Effects of tablet and effervescent formulations of ranitidine 75 mg and cimetidine 200 mg on gastric acidity and oesophageal acid exposure in healthy humans.
Bruley des Varannes S; Duquesnoy C; Mamet JP; Slama A; Galmiche JP; Scarpignato C
Aliment Pharmacol Ther; 1998 Nov; 12(11):1155-61. PubMed ID: 9845405
[TBL] [Abstract][Full Text] [Related]
15. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
[TBL] [Abstract][Full Text] [Related]
16. The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.
Abe Y; Inamori M; Togawa J; Kikuchi T; Muramatsu K; Chiguchi G; Kawamura H; Kobayashi N; Kirikoshi H; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol; 2004 Jan; 39(1):21-5. PubMed ID: 14767730
[TBL] [Abstract][Full Text] [Related]
17. Effervescent and standard formulations of ranitidine--a comparison of their pharmacokinetics and pharmacology.
Watson RG; Johnston BT; Tham TC; Kersey K
Aliment Pharmacol Ther; 1996 Dec; 10(6):913-8. PubMed ID: 8971288
[TBL] [Abstract][Full Text] [Related]
18. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
19. Nocturnal intragastric acidity after over-the-counter doses of famotidine, ranitidine or placebo.
Grimley CE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1997 Oct; 11(5):881-5. PubMed ID: 9354196
[TBL] [Abstract][Full Text] [Related]
20. Effects of effervescent ranitidine on gastric pH: comparison with almagate and placebo in fasting and postprandial conditions.
Rey E; Poves-Francés C; Sánchez G; Fueyo A; Badiola C; Díaz-Rubio M
Aliment Pharmacol Ther; 2004 Sep; 20(6):683-8. PubMed ID: 15352917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]